Sign inJoin waitlistJoin the waitlist

LC

Lee Cranmer

Physician · City of Hope

Credentials: · · · · · · ·

History

City of Hope
2025–Present

Medical Oncology
2001–2003
Internal Medicine
1998–2001
University of California, Irvine School of Medicine
1994–1998

Research

Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Journal of Clinical Oncology · 2015 · 2,112 citations
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
The Lancet Oncology · 2015 · 1,307 citations
Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre,…
The Lancet Oncology · 2017 · 258 citations

Michael Wagner
22 papers
Seth Pollack
21 papers
Elizabeth Loggers
19 papers
RJ
Robin Jones
13 papers
EH
Evan Hersh
8 papers
RG
Rene Gonzalez-Cotarelo
8 papers
BS
Brett Schroeder
7 papers · 6 as a resident
Igor Puzanov
7 papers
Kristen Ganjoo
7 papers
Antoni Ribas
6 papers
BT
Brian Van Tine
6 papers
David Lawson
6 papers

Grants

Southwest Oncology Group ca13612
National Cancer Institute · U10
Contact PI · $481K · University of Arizona
1978–2014

Clinical trials

Cabozantinib With Radiation Therapy for the Treatment of Sarcomas of the Extremities
Principal investigator · Terminated · Phase 1, Phase 2
University of Washington
2020–2024
Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas
Principal investigator · Terminated · Phase 1
Fred Hutchinson Cancer Center
2019–2024
Nab-Sirolimus and Pazopanib Hydrochloride in Treating Patients With Advanced Nonadipocytic Soft Tissue Sarcomas
Principal investigator · Terminated · Phase 1, Phase 2
University of Washington
2019–2024
Pembrolizumab and Radiation Therapy in Treating Patients With Intermediate or High-Grade Soft Tissue Sarcoma
Principal investigator · Completed · Phase 1, Phase 2
Fred Hutchinson Cancer Center
2018–2023